These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 32933353
1. Combined treatment with immunoglobulin and valaciclovir in pregnant women with cytomegalovirus infection and high risk of symptomatic fetal disease. De la Calle M, Baquero-Artigao F, Rodríguez-Molino P, Cabanes M, Cabrera M, Antolin E, Mellado MJ, Bartha JL. J Matern Fetal Neonatal Med; 2022 Aug; 35(16):3196-3200. PubMed ID: 32933353 [Abstract] [Full Text] [Related]
2. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid. Blázquez-Gamero D, Galindo Izquierdo A, Del Rosal T, Baquero-Artigao F, Izquierdo Méndez N, Soriano-Ramos M, Rojo Conejo P, González-Tomé MI, García-Burguillo A, Pérez Pérez N, Sánchez V, Ramos-Amador JT, De la Calle M. J Matern Fetal Neonatal Med; 2019 Feb; 32(4):617-625. PubMed ID: 28978246 [Abstract] [Full Text] [Related]
5. Prevention of Congenital Cytomegalovirus Infection: Review and Case Series of Valaciclovir versus Hyperimmune Globulin Therapy. Nigro G, Muselli M, On Behalf Of The Congenital Cytomegalic Disease Collaborating Group. Viruses; 2023 Jun 15; 15(6):. PubMed ID: 37376675 [Abstract] [Full Text] [Related]
6. Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis. D'Antonio F, Marinceu D, Prasad S, Khalil A. Ultrasound Obstet Gynecol; 2023 Apr 15; 61(4):436-444. PubMed ID: 36484439 [Abstract] [Full Text] [Related]
7. Risk of congenital cytomegalovirus infection in children born to women with IgG avidity in the grey zone during first trimester of pregnancy. Kekkou K, Kavatha D, Karalexi M, Galani L, Dimopoulou D, Papaevangelou V, Antoniadou A. J Matern Fetal Neonatal Med; 2021 Jun 15; 34(12):2025-2029. PubMed ID: 31401915 [Abstract] [Full Text] [Related]
8. Outcome of pregnancies with recent primary cytomegalovirus infection in first trimester treated with hyperimmunoglobulin: observational study. Kagan KO, Enders M, Hoopmann M, Geipel A, Simonini C, Berg C, Gottschalk I, Faschingbauer F, Schneider MO, Ganzenmueller T, Hamprecht K. Ultrasound Obstet Gynecol; 2021 Apr 15; 57(4):560-567. PubMed ID: 33491819 [Abstract] [Full Text] [Related]
11. Maternal high-dose valacyclovir and its correlation with newborn blood viral load and outcome in congenital cytomegalovirus infection. Goncé A, Hawkins-Villarreal A, Salazar L, Guirado L, Marcos MA, Pascual Mancho J, Prats P, López M, Eixarch E, Salvia MD, Fortuny C, Figueras F. J Matern Fetal Neonatal Med; 2022 Oct 15; 35(20):4004-4008. PubMed ID: 33143511 [Abstract] [Full Text] [Related]
14. Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis. Seidel V, Hackelöer M, Rancourt RC, Henrich W, Siedentopf JP. Arch Gynecol Obstet; 2020 Dec 15; 302(6):1353-1359. PubMed ID: 32754858 [Abstract] [Full Text] [Related]
18. Describing the Impact of Maternal Hyperimmune Globulin and Valacyclovir on the Outcomes of Cytomegalovirus Infection in Pregnancy: A Systematic Review. Fitzpatrick A, Cooper C, Vasilunas N, Ritchie B. Clin Infect Dis; 2022 Oct 12; 75(8):1467-1480. PubMed ID: 35438780 [Abstract] [Full Text] [Related]
19. Screening, diagnosis, and management of cytomegalovirus infection in pregnancy. Yinon Y, Farine D, Yudin MH. Obstet Gynecol Surv; 2010 Nov 12; 65(11):736-43. PubMed ID: 21375790 [Abstract] [Full Text] [Related]